Our findings also showed that a higher serum level of AFP was an independent predictor of MVI in cHCC-CCA, but when the serum level of AFP was between 20 and 400 ng/ml, there were no significant differences in MVI. This evidence concerns the gene AFP and cholangiocarcinoma.